Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy aims to ease bladder leakage in women

NCT ID NCT07576205

Symptom relief Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether combining Paula exercises (a type of pelvic floor training) with tibial nerve stimulation (a non-invasive nerve treatment) can help women with stress urinary incontinence. The goal is to reduce leakage, strengthen pelvic muscles, improve sexual function, and boost quality of life. About 52 women who have had at least two vaginal deliveries and have had symptoms for three months or more will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 52 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Multiparous women (≥2 full-term vaginal deliveries) * Clinical diagnosis of stress urinary incontinence (confirmed by cough stress test) * Duration of symptoms ≥3 months * Ability to correctly perform pelvic floor contractions (confirmed by digital examination) Exclusion Criteria: * Neurological disorders (e.g., multiple sclerosis, spinal cord injury) * Mixed or urge urinary incontinence as the predominant type * Previous pelvic surgery or incontinence-related procedures within the past year * Current pregnancy or \<6 months postpartum * Pelvic organ prolapse beyond stage II (POP-Q system) * Current use of other incontinence therapies (e.g., medication, PTNS, PFMT) * Diagnosed malignancy * Diagnosed psychiatric disorder * Pregnancy * Diagnosed dermatological condition * Participants who are currently enrolled in other clinical trials to avoid potential confounding factors.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urinary incontinence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence Urinary Incontinence, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urinary incontinence

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Arshian Hussnain Medical Clinic

    RECRUITING

    Lahore, Punjab Province, 6400, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.